Viridian Therapeutics, Inc.VRDNNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+10.9%
5Y CAGR+35.9%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+10.9%/yr
vs +47.8%/yr prior
5Y CAGR
+35.9%/yr
Recent deceleration
Acceleration
-36.9pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.6x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $212.38M | +113.2% |
| 2024 | $99.59M | -3.1% |
| 2023 | $102.83M | -33.9% |
| 2022 | $155.58M | +267.8% |
| 2021 | $42.30M | -7.8% |
| 2020 | $45.90M | +84.7% |
| 2019 | $24.85M | -23.8% |
| 2018 | $32.61M | -31.3% |
| 2017 | $47.44M | +1320.0% |
| 2016 | $3.34M | - |